Compare Agilent Technologies Inc (A) vs iShares 3 7 Year Treasury Bond ETF (IEI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs iShares 3 7 Year Treasury Bond ETF — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.22B), while iShares 3 7 Year Treasury Bond ETF trades at $116.73. The key difference: Agilent Technologies Inc pays a 0.68% dividend while iShares 3 7 Year Treasury Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | IEI | |
|---|---|---|
Market Cap | $42.22B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $120.72 |
52-Week Low | $110.24 | $116.16 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IEI trades at $116.55, up 0.19% on the day, with a neutral technical signal and bearish moving averages. The ETF shows consistent dividend payouts, with recent distributions of $0.37-$0.38. Treasury yield volatility, driven by inflation data and geopolitical tensions, influences price action, while institutional interest is mixed, with Bank of America increasing its stake as of August 2026.
Outlook remains tied to Federal Reserve policy and inflation trends, offering stability but limited growth. Risks include rising yields pressuring bond prices and Middle East instability affecting oil markets. Income-focused investors may find value in its government-backed yield amid ongoing market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares 3 7 Year Treasury Bond ETF
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →
